|
|
Macular Telangiectasia - Mild19 views56 year old female with good vision and mild macular telangiectasia. VA 20/40 OD 20/16 OSDec 30, 2019
|
|
Macular Telangiectasia - Mild20 views56 year old female with good vision and mild macular telangiectasia. VA 20/40 OD 20/16 OSDec 30, 2019
|
|
Macular Telangiectasia - Mild3 views56 year old female with good vision and mild macular telangiectasia. VA 20/40 OD 20/16 OSDec 30, 2019
|
|
Macular Telangiectasia - Mild2 views56 year old female with good vision and mild macular telangiectasia. VA 20/40 OD 20/16 OSDec 30, 2019
|
|
Macular Telangiectasia - Mild2 views56 year old female with good vision and mild macular telangiectasia. VA 20/40 OD 20/16 OSDec 30, 2019
|
|
Macular Telangiectasia - Mild2 views56 year old female with good vision and mild macular telangiectasia. VA 20/40 OD 20/16 OSDec 30, 2019
|
|
Macular Telangiectasia - Mild2 views56 year old female with good vision and mild macular telangiectasia. VA 20/40 OD 20/16 OSDec 30, 2019
|
|
Macular Telangiectasia - Mild2 views56 year old female with good vision and mild macular telangiectasia. VA 20/40 OD 20/16 OSDec 30, 2019
|
|
Macular Telangiectasia - Mild2 views56 year old female with good vision and mild macular telangiectasia. VA 20/40 OD 20/16 OSDec 30, 2019
|
|
Macular Telangiectasia - Mild2 views56 year old female with good vision and mild macular telangiectasia. VA 20/40 OD 20/16 OSDec 30, 2019
|
|
Macular Telangiectasia - Mild2 views56 year old female with good vision and mild macular telangiectasia. VA 20/40 OD 20/16 OSDec 30, 2019
|
|
Macular Telangiectasia - Mild2 views56 year old female with good vision and mild macular telangiectasia. VA 20/40 OD 20/16 OSDec 30, 2019
|
|
Macular Telangiectasia - Mild2 views56 year old female with good vision and mild macular telangiectasia. VA 20/40 OD 20/16 OSDec 30, 2019
|
|
Macular Telangiectasia - Mild2 views56 year old female with good vision and mild macular telangiectasia. VA 20/40 OD 20/16 OSDec 30, 2019
|
|
Concentric Geographic Atrophy - 76 year old man3 viewsGradual vision loss, worse at night. VA 20/40 OU.Dec 30, 2019
|
|
Concentric Geographic Atrophy - 76 year old man3 viewsGradual vision loss, worse at night. VA 20/40 OU.Dec 30, 2019
|
|
Concentric Geographic Atrophy - 76 year old man3 viewsGradual vision loss, worse at night. VA 20/40 OU.Dec 30, 2019
|
|
Concentric Geographic Atrophy - 76 year old man3 viewsGradual vision loss, worse at night. VA 20/40 OU.Dec 30, 2019
|
|
Concentric Geographic Atrophy - 76 year old man4 viewsGradual vision loss, worse at night. VA 20/40 OU.Dec 30, 2019
|
|
Concentric Geographic Atrophy - 76 year old man2 viewsGradual vision loss, worse at night. VA 20/40 OU.Dec 30, 2019
|
|
Concentric Geographic Atrophy - 76 year old man2 viewsGradual vision loss, worse at night. VA 20/40 OU.Dec 30, 2019
|
|
Concentric Geographic Atrophy - 76 year old man2 viewsGradual vision loss, worse at night. VA 20/40 OU.Dec 30, 2019
|
|
Concentric Geographic Atrophy - 76 year old man3 viewsGradual vision loss, worse at night. VA 20/40 OU.Dec 30, 2019
|
|
Concentric Geographic Atrophy - 76 year old man3 viewsGradual vision loss, worse at night. VA 20/40 OU.Dec 30, 2019
|
|
Concentric Geographic Atrophy - 76 year old man3 viewsGradual vision loss, worse at night. VA 20/40 OU.Dec 30, 2019
|
|
Concentric Geographic Atrophy - 76 year old man3 viewsGradual vision loss, worse at night. VA 20/40 OU.Dec 30, 2019
|
|
Concentric Geographic Atrophy - 76 year old man3 viewsGradual vision loss, worse at night. VA 20/40 OU.Dec 30, 2019
|
|
Concentric Geographic Atrophy - 76 year old man3 viewsGradual vision loss, worse at night. VA 20/40 OU.Dec 30, 2019
|
|
Concentric Geographic Atrophy - 76 year old man3 viewsGradual vision loss, worse at night. VA 20/40 OU.Dec 30, 2019
|
|
Concentric Geographic Atrophy - 76 year old man3 viewsGradual vision loss, worse at night. VA 20/40 OU.Dec 30, 2019
|
|
Asteroid Hyalosis - Clarus Color Image2 viewsDec 30, 2019
|
|
Asteroid Hyalosis - Clarus Color Image2 viewsDec 30, 2019
|
|
PDR and DME and VH2 views57 year old diabetic man with vision loss in the left eye for several months. He has DME in the left eye and VH in the left eye and PDR in both eyes. He has been started in the left eye on Anti-VEGF therapy. VA on presentation was 20/25 OD and 20/200 OSDec 30, 2019
|
|
PDR and DME and VH2 views57 year old diabetic man with vision loss in the left eye for several months. He has DME in the left eye and VH in the left eye and PDR in both eyes. He has been started in the left eye on Anti-VEGF therapy. VA on presentation was 20/25 OD and 20/200 OSDec 30, 2019
|
|
PDR and DME and VH2 views57 year old diabetic man with vision loss in the left eye for several months. He has DME in the left eye and VH in the left eye and PDR in both eyes. He has been started in the left eye on Anti-VEGF therapy. VA on presentation was 20/25 OD and 20/200 OSDec 30, 2019
|
|
PDR and DME and VH2 views57 year old diabetic man with vision loss in the left eye for several months. He has DME in the left eye and VH in the left eye and PDR in both eyes. He has been started in the left eye on Anti-VEGF therapy. VA on presentation was 20/25 OD and 20/200 OSDec 30, 2019
|
|
PDR and DME and VH2 views57 year old diabetic man with vision loss in the left eye for several months. He has DME in the left eye and VH in the left eye and PDR in both eyes. He has been started in the left eye on Anti-VEGF therapy. VA on presentation was 20/25 OD and 20/200 OSDec 30, 2019
|
|
PDR and DME and VH2 views57 year old diabetic man with vision loss in the left eye for several months. He has DME in the left eye and VH in the left eye and PDR in both eyes. He has been started in the left eye on Anti-VEGF therapy. VA on presentation was 20/25 OD and 20/200 OSDec 30, 2019
|
|
PDR and DME and VH2 views57 year old diabetic man with vision loss in the left eye for several months. He has DME in the left eye and VH in the left eye and PDR in both eyes. He has been started in the left eye on Anti-VEGF therapy. VA on presentation was 20/25 OD and 20/200 OSDec 30, 2019
|
|
PDR and DME and VH2 views57 year old diabetic man with vision loss in the left eye for several months. He has DME in the left eye and VH in the left eye and PDR in both eyes. He has been started in the left eye on Anti-VEGF therapy. VA on presentation was 20/25 OD and 20/200 OSDec 30, 2019
|
|
PDR and DME and VH2 views57 year old diabetic man with vision loss in the left eye for several months. He has DME in the left eye and VH in the left eye and PDR in both eyes. He has been started in the left eye on Anti-VEGF therapy. VA on presentation was 20/25 OD and 20/200 OSDec 30, 2019
|
|
PDR and DME and VH2 views57 year old diabetic man with vision loss in the left eye for several months. He has DME in the left eye and VH in the left eye and PDR in both eyes. He has been started in the left eye on Anti-VEGF therapy. VA on presentation was 20/25 OD and 20/200 OSDec 30, 2019
|
|
PDR and DME and VH2 views57 year old diabetic man with vision loss in the left eye for several months. He has DME in the left eye and VH in the left eye and PDR in both eyes. He has been started in the left eye on Anti-VEGF therapy. VA on presentation was 20/25 OD and 20/200 OSDec 30, 2019
|
|
PDR and DME and VH2 views57 year old diabetic man with vision loss in the left eye for several months. He has DME in the left eye and VH in the left eye and PDR in both eyes. He has been started in the left eye on Anti-VEGF therapy. VA on presentation was 20/25 OD and 20/200 OSDec 30, 2019
|
|
PDR and DME and VH2 views57 year old diabetic man with vision loss in the left eye for several months. He has DME in the left eye and VH in the left eye and PDR in both eyes. He has been started in the left eye on Anti-VEGF therapy. VA on presentation was 20/25 OD and 20/200 OSDec 30, 2019
|
|
PDR and DME and VH2 views57 year old diabetic man with vision loss in the left eye for several months. He has DME in the left eye and VH in the left eye and PDR in both eyes. He has been started in the left eye on Anti-VEGF therapy. VA on presentation was 20/25 OD and 20/200 OSDec 30, 2019
|
|
PDR and DME and VH2 views57 year old diabetic man with vision loss in the left eye for several months. He has DME in the left eye and VH in the left eye and PDR in both eyes. He has been started in the left eye on Anti-VEGF therapy. VA on presentation was 20/25 OD and 20/200 OSDec 30, 2019
|
|
PDR and DME and VH2 views57 year old diabetic man with vision loss in the left eye for several months. He has DME in the left eye and VH in the left eye and PDR in both eyes. He has been started in the left eye on Anti-VEGF therapy. VA on presentation was 20/25 OD and 20/200 OSDec 30, 2019
|
|
PDR and DME and VH2 views57 year old diabetic man with vision loss in the left eye for several months. He has DME in the left eye and VH in the left eye and PDR in both eyes. He has been started in the left eye on Anti-VEGF therapy. VA on presentation was 20/25 OD and 20/200 OSDec 30, 2019
|
|
PDR and DME and VH2 views57 year old diabetic man with vision loss in the left eye for several months. He has DME in the left eye and VH in the left eye and PDR in both eyes. He has been started in the left eye on Anti-VEGF therapy. VA on presentation was 20/25 OD and 20/200 OSDec 30, 2019
|
|
PDR and DME and VH2 views57 year old diabetic man with vision loss in the left eye for several months. He has DME in the left eye and VH in the left eye and PDR in both eyes. He has been started in the left eye on Anti-VEGF therapy. VA on presentation was 20/25 OD and 20/200 OSDec 30, 2019
|
|
PDR and DME and VH2 views57 year old diabetic man with vision loss in the left eye for several months. He has DME in the left eye and VH in the left eye and PDR in both eyes. He has been started in the left eye on Anti-VEGF therapy. VA on presentation was 20/25 OD and 20/200 OSDec 30, 2019
|
|
PDR and DME and VH2 views57 year old diabetic man with vision loss in the left eye for several months. He has DME in the left eye and VH in the left eye and PDR in both eyes. He has been started in the left eye on Anti-VEGF therapy. VA on presentation was 20/25 OD and 20/200 OSDec 30, 2019
|
|
PDR and DME and VH2 views57 year old diabetic man with vision loss in the left eye for several months. He has DME in the left eye and VH in the left eye and PDR in both eyes. He has been started in the left eye on Anti-VEGF therapy. VA on presentation was 20/25 OD and 20/200 OSDec 30, 2019
|
|
PDR and DME and VH2 views57 year old diabetic man with vision loss in the left eye for several months. He has DME in the left eye and VH in the left eye and PDR in both eyes. He has been started in the left eye on Anti-VEGF therapy. VA on presentation was 20/25 OD and 20/200 OSDec 30, 2019
|
|
PDR and DME and VH2 views57 year old diabetic man with vision loss in the left eye for several months. He has DME in the left eye and VH in the left eye and PDR in both eyes. He has been started in the left eye on Anti-VEGF therapy. VA on presentation was 20/25 OD and 20/200 OSDec 30, 2019
|
|
PDR and DME and VH2 views57 year old diabetic man with vision loss in the left eye for several months. He has DME in the left eye and VH in the left eye and PDR in both eyes. He has been started in the left eye on Anti-VEGF therapy. VA on presentation was 20/25 OD and 20/200 OSDec 30, 2019
|
|
PDR and DME and VH2 views57 year old diabetic man with vision loss in the left eye for several months. He has DME in the left eye and VH in the left eye and PDR in both eyes. He has been started in the left eye on Anti-VEGF therapy. VA on presentation was 20/25 OD and 20/200 OSDec 30, 2019
|
|
PDR and DME and VH2 views57 year old diabetic man with vision loss in the left eye for several months. He has DME in the left eye and VH in the left eye and PDR in both eyes. He has been started in the left eye on Anti-VEGF therapy. VA on presentation was 20/25 OD and 20/200 OSDec 30, 2019
|
|
PDR and DME and VH2 views57 year old diabetic man with vision loss in the left eye for several months. He has DME in the left eye and VH in the left eye and PDR in both eyes. He has been started in the left eye on Anti-VEGF therapy. VA on presentation was 20/25 OD and 20/200 OSDec 30, 2019
|
|
Punctate Inner Choroidopathy and Choroidal Neovascular Membrane2 views27 year old female with vision loss for 4 months. VA was 20/200. She had a CNVM which was extrafoveal with no subretinal fluid. Her vision improved over 6 months to 20/50 with Ranibizumab injections (she might have improved without treatment)Dec 30, 2019
|
|
Punctate Inner Choroidopathy and Choroidal Neovascular Membrane2 views27 year old female with vision loss for 4 months. VA was 20/200. She had a CNVM which was extrafoveal with no subretinal fluid. Her vision improved over 6 months to 20/50 with Ranibizumab injections (she might have improved without treatment)Dec 30, 2019
|
|
Punctate Inner Choroidopathy and Choroidal Neovascular Membrane3 views27 year old female with vision loss for 4 months. VA was 20/200. She had a CNVM which was extrafoveal with no subretinal fluid. Her vision improved over 6 months to 20/50 with Ranibizumab injections (she might have improved without treatment)Dec 30, 2019
|
|
Punctate Inner Choroidopathy and Choroidal Neovascular Membrane2 views27 year old female with vision loss for 4 months. VA was 20/200. She had a CNVM which was extrafoveal with no subretinal fluid. Her vision improved over 6 months to 20/50 with Ranibizumab injections (she might have improved without treatment)Dec 30, 2019
|
|
Punctate Inner Choroidopathy and Choroidal Neovascular Membrane3 views27 year old female with vision loss for 4 months. VA was 20/200. She had a CNVM which was extrafoveal with no subretinal fluid. Her vision improved over 6 months to 20/50 with Ranibizumab injections (she might have improved without treatment)Dec 30, 2019
|
|
Punctate Inner Choroidopathy and Choroidal Neovascular Membrane3 views27 year old female with vision loss for 4 months. VA was 20/200. She had a CNVM which was extrafoveal with no subretinal fluid. Her vision improved over 6 months to 20/50 with Ranibizumab injections (she might have improved without treatment)Dec 30, 2019
|
|
Punctate Inner Choroidopathy and Choroidal Neovascular Membrane3 views27 year old female with vision loss for 4 months. VA was 20/200. She had a CNVM which was extrafoveal with no subretinal fluid. Her vision improved over 6 months to 20/50 with Ranibizumab injections (she might have improved without treatment)Dec 30, 2019
|
|
Punctate Inner Choroidopathy and Choroidal Neovascular Membrane2 views27 year old female with vision loss for 4 months. VA was 20/200. She had a CNVM which was extrafoveal with no subretinal fluid. Her vision improved over 6 months to 20/50 with Ranibizumab injections (she might have improved without treatment)Dec 30, 2019
|
|
Punctate Inner Choroidopathy and Choroidal Neovascular Membrane3 views27 year old female with vision loss for 4 months. VA was 20/200. She had a CNVM which was extrafoveal with no subretinal fluid. Her vision improved over 6 months to 20/50 with Ranibizumab injections (she might have improved without treatment)Dec 30, 2019
|
|
Punctate Inner Choroidopathy and Choroidal Neovascular Membrane2 views27 year old female with vision loss for 4 months. VA was 20/200. She had a CNVM which was extrafoveal with no subretinal fluid. Her vision improved over 6 months to 20/50 with Ranibizumab injections (she might have improved without treatment)Dec 30, 2019
|
|
Punctate Inner Choroidopathy and Choroidal Neovascular Membrane3 views27 year old female with vision loss for 4 months. VA was 20/200. She had a CNVM which was extrafoveal with no subretinal fluid. Her vision improved over 6 months to 20/50 with Ranibizumab injections (she might have improved without treatment)Dec 30, 2019
|
|
Punctate Inner Choroidopathy and Choroidal Neovascular Membrane2 views27 year old female with vision loss for 4 months. VA was 20/200. She had a CNVM which was extrafoveal with no subretinal fluid. Her vision improved over 6 months to 20/50 with Ranibizumab injections (she might have improved without treatment)Dec 30, 2019
|
|
Punctate Inner Choroidopathy and Choroidal Neovascular Membrane3 views27 year old female with vision loss for 4 months. VA was 20/200. She had a CNVM which was extrafoveal with no subretinal fluid. Her vision improved over 6 months to 20/50 with Ranibizumab injections (she might have improved without treatment)Dec 30, 2019
|
|
Punctate Inner Choroidopathy and Choroidal Neovascular Membrane2 views27 year old female with vision loss for 4 months. VA was 20/200. She had a CNVM which was extrafoveal with no subretinal fluid. Her vision improved over 6 months to 20/50 with Ranibizumab injections (she might have improved without treatment)Dec 30, 2019
|
|
Punctate Inner Choroidopathy and Choroidal Neovascular Membrane3 views27 year old female with vision loss for 4 months. VA was 20/200. She had a CNVM which was extrafoveal with no subretinal fluid. Her vision improved over 6 months to 20/50 with Ranibizumab injections (she might have improved without treatment)Dec 30, 2019
|
|
Punctate Inner Choroidopathy and Choroidal Neovascular Membrane2 views27 year old female with vision loss for 4 months. VA was 20/200. She had a CNVM which was extrafoveal with no subretinal fluid. Her vision improved over 6 months to 20/50 with Ranibizumab injections (she might have improved without treatment)Dec 30, 2019
|
|
Punctate Inner Choroidopathy and Choroidal Neovascular Membrane4 views27 year old female with vision loss for 4 months. VA was 20/200. She had a CNVM which was extrafoveal with no subretinal fluid. Her vision improved over 6 months to 20/50 with Ranibizumab injections (she might have improved without treatment)Dec 30, 2019
|
|
Punctate Inner Choroidopathy and Choroidal Neovascular Membrane2 views27 year old female with vision loss for 4 months. VA was 20/200. She had a CNVM which was extrafoveal with no subretinal fluid. Her vision improved over 6 months to 20/50 with Ranibizumab injections (she might have improved without treatment)Dec 30, 2019
|
|
Punctate Inner Choroidopathy and Choroidal Neovascular Membrane2 views27 year old female with vision loss for 4 months. VA was 20/200. She had a CNVM which was extrafoveal with no subretinal fluid. Her vision improved over 6 months to 20/50 with Ranibizumab injections (she might have improved without treatment)Dec 30, 2019
|
|
Punctate Inner Choroidopathy and Choroidal Neovascular Membrane3 views27 year old female with vision loss for 4 months. VA was 20/200. She had a CNVM which was extrafoveal with no subretinal fluid. Her vision improved over 6 months to 20/50 with Ranibizumab injections (she might have improved without treatment)Dec 30, 2019
|
|
Punctate Inner Choroidopathy and Choroidal Neovascular Membrane2 views27 year old female with vision loss for 4 months. VA was 20/200. She had a CNVM which was extrafoveal with no subretinal fluid. Her vision improved over 6 months to 20/50 with Ranibizumab injections (she might have improved without treatment)Dec 30, 2019
|
|
Punctate Inner Choroidopathy and Choroidal Neovascular Membrane3 views27 year old female with vision loss for 4 months. VA was 20/200. She had a CNVM which was extrafoveal with no subretinal fluid. Her vision improved over 6 months to 20/50 with Ranibizumab injections (she might have improved without treatment)Dec 30, 2019
|
|
Punctate Inner Choroidopathy and Choroidal Neovascular Membrane2 views27 year old female with vision loss for 4 months. VA was 20/200. She had a CNVM which was extrafoveal with no subretinal fluid. Her vision improved over 6 months to 20/50 with Ranibizumab injections (she might have improved without treatment)Dec 30, 2019
|
|
Punctate Inner Choroidopathy and Choroidal Neovascular Membrane2 views27 year old female with vision loss for 4 months. VA was 20/200. She had a CNVM which was extrafoveal with no subretinal fluid. Her vision improved over 6 months to 20/50 with Ranibizumab injections (she might have improved without treatment)Dec 30, 2019
|
|
Punctate Inner Choroidopathy and Choroidal Neovascular Membrane2 views27 year old female with vision loss for 4 months. VA was 20/200. She had a CNVM which was extrafoveal with no subretinal fluid. Her vision improved over 6 months to 20/50 with Ranibizumab injections (she might have improved without treatment)Dec 30, 2019
|
|
Punctate Inner Choroidopathy and Choroidal Neovascular Membrane2 views27 year old female with vision loss for 4 months. VA was 20/200. She had a CNVM which was extrafoveal with no subretinal fluid. Her vision improved over 6 months to 20/50 with Ranibizumab injections (she might have improved without treatment)Dec 30, 2019
|
|
Punctate Inner Choroidopathy and Choroidal Neovascular Membrane2 views27 year old female with vision loss for 4 months. VA was 20/200. She had a CNVM which was extrafoveal with no subretinal fluid. Her vision improved over 6 months to 20/50 with Ranibizumab injections (she might have improved without treatment)Dec 30, 2019
|
|
Punctate Inner Choroidopathy and Choroidal Neovascular Membrane2 views27 year old female with vision loss for 4 months. VA was 20/200. She had a CNVM which was extrafoveal with no subretinal fluid. Her vision improved over 6 months to 20/50 with Ranibizumab injections (she might have improved without treatment)Dec 30, 2019
|
|
Punctate Inner Choroidopathy and Choroidal Neovascular Membrane2 views27 year old female with vision loss for 4 months. VA was 20/200. She had a CNVM which was extrafoveal with no subretinal fluid. Her vision improved over 6 months to 20/50 with Ranibizumab injections (she might have improved without treatment)Dec 30, 2019
|
|
Punctate Inner Choroidopathy and Choroidal Neovascular Membrane2 views27 year old female with vision loss for 4 months. VA was 20/200. She had a CNVM which was extrafoveal with no subretinal fluid. Her vision improved over 6 months to 20/50 with Ranibizumab injections (she might have improved without treatment)Dec 30, 2019
|
|
Punctate Inner Choroidopathy and Choroidal Neovascular Membrane2 views27 year old female with vision loss for 4 months. VA was 20/200. She had a CNVM which was extrafoveal with no subretinal fluid. Her vision improved over 6 months to 20/50 with Ranibizumab injections (she might have improved without treatment)Dec 30, 2019
|
|
Punctate Inner Choroidopathy and Choroidal Neovascular Membrane2 views27 year old female with vision loss for 4 months. VA was 20/200. She had a CNVM which was extrafoveal with no subretinal fluid. Her vision improved over 6 months to 20/50 with Ranibizumab injections (she might have improved without treatment)Dec 30, 2019
|
|
Punctate Inner Choroidopathy and Choroidal Neovascular Membrane2 views27 year old female with vision loss for 4 months. VA was 20/200. She had a CNVM which was extrafoveal with no subretinal fluid. Her vision improved over 6 months to 20/50 with Ranibizumab injections (she might have improved without treatment)Dec 30, 2019
|
|
Punctate Inner Choroidopathy and Choroidal Neovascular Membrane2 views27 year old female with vision loss for 4 months. VA was 20/200. She had a CNVM which was extrafoveal with no subretinal fluid. Her vision improved over 6 months to 20/50 with Ranibizumab injections (she might have improved without treatment)Dec 30, 2019
|
|
Punctate Inner Choroidopathy and Choroidal Neovascular Membrane2 views27 year old female with vision loss for 4 months. VA was 20/200. She had a CNVM which was extrafoveal with no subretinal fluid. Her vision improved over 6 months to 20/50 with Ranibizumab injections (she might have improved without treatment)Dec 30, 2019
|
|
Punctate Inner Choroidopathy and Choroidal Neovascular Membrane3 views27 year old female with vision loss for 4 months. VA was 20/200. She had a CNVM which was extrafoveal with no subretinal fluid. Her vision improved over 6 months to 20/50 with Ranibizumab injections (she might have improved without treatment)Dec 30, 2019
|
|
Punctate Inner Choroidopathy and Choroidal Neovascular Membrane2 views27 year old female with vision loss for 4 months. VA was 20/200. She had a CNVM which was extrafoveal with no subretinal fluid. Her vision improved over 6 months to 20/50 with Ranibizumab injections (she might have improved without treatment)Dec 30, 2019
|
|
Punctate Inner Choroidopathy and Choroidal Neovascular Membrane2 views27 year old female with vision loss for 4 months. VA was 20/200. She had a CNVM which was extrafoveal with no subretinal fluid. Her vision improved over 6 months to 20/50 with Ranibizumab injections (she might have improved without treatment)Dec 30, 2019
|
|
Angioid Streaks Scar and new CNVM9 views49 y/o WF with decreased vision x 1 month. Her OD is 20/400 and her OS is seeing 20/70. No cutaneous lesions or Ehlers-Danlos. The FP and FA show a predominant classic CNV (with fibrosis) OD and an Occult CNV OS with what appears to be a RAP lesion.Dec 21, 2019
|
|
Angioid Streaks Scar and new CNVM9 views49 y/o WF with decreased vision x 1 month. Her OD is 20/400 and her OS is seeing 20/70. No cutaneous lesions or Ehlers-Danlos. The FP and FA show a predominant classic CNV (with fibrosis) OD and an Occult CNV OS with what appears to be a RAP lesion.Dec 21, 2019
|
|
| 12245 files on 123 page(s) |
1 |
 |
|
|
|
|
|
|
|
|
|
